Explore our easy plasmid services starting at just $249. Our fully sequenced plasmids, ready for your research, include a miniprep. Reduce project cos...
Taking the right first-time approach to optimize end to end viral vector manufacturing process
- Improve performance of your process by relying on innovative plasmid engineering and transfection reagents
- Improve cost-effectiveness of your manufacturing process through end-to-end scientific support for process scale-up and process intensification
- Reduce time to market with Polyplus’ end-to-end regulatory support to facilitate your regulatory journey to reach cGMP compliance
Featured products for Cell and Gene Therapy
Did you know that we’ve made it possible for you to improve your lentiviral yields, while reducing the amount of DNA needed? FectoVIR®-LV is the brand new transfection reagent on the block ready to boost your productivity, reduce your cost and allow you to scale-up your process. The Cherry on top? we provide complementary DOE service to fast-track your optimization!
Discover Cell and Gene Therapy solutions
pPLUS® AAV-Helper is a novel plasmid helper designed for AAV production. This plasmid has been optimized for triple transfection of HEK293 cells in s...
Available at research and GMP grade to intensify production of recombinant AAV rAAV viral vectors at any scale from benchtop to 2000L scale bioreactor...
PEIpro® is the leading PEI-based DNA transfection reagent that offers flexibility and scalability for viral vector manufacturing.
Polyplus provides an integrated service for design and production of tailor-made DNA plasmid through our unique and Innovative assembly technology.
Polyplus offers a comprehensive range of plasmid manufacturing services from DNA plasmid design to plasmid DNA manufacturing and analytical testing.
Discover Our Applications
RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They offer substantial advantages in terms of reliability,safety and costs for nucleic-acid based therapies
Broad range of solutions is needed for manufacturing of functional proteins or antibodies at the desired scale in bacteria, yeast and mammalian cell expression systems
Optimised plasmid engineering and specific transfection reagents are key to enable protein expression in a wide range of adherent and suspension mammalian cell types